How to Trip Rapid Review

Step 1: Select articles relevant to your search (remember the system is only optimised for single intervention studies)

Step 2: press

Step 3: review the result, and maybe amend the or if you know better! If we're unsure of the overall sentiment of the trial we will display the conclusion under the article title. We then require you to tell us what the correct sentiment is.

6,247 results for

Depression Screening Tools

by
...
Latest & greatest
Alerts

Export results

Use check boxes to select individual results below

SmartSearch available

Trip's SmartSearch engine has discovered connected searches & results. Click to show

141. Validation of the STarT Back Screening Tool in the Military

Validation of the STarT Back Screening Tool in the Military Validation of the STarT Back Screening Tool in the Military - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (100). Please remove one or more studies before adding more. Validation of the STarT Back Screening (...) Information provided by (Responsible Party): Dan Rhon, Brooke Army Medical Center Study Details Study Description Go to Brief Summary: This is a trial to validate the use of the STarT Back Screening Tool (SBST) in the Military Health System for patients with low back pain presenting to primary care. Condition or disease Intervention/treatment Phase Low Back Pain Lumbago Radiculopathy Intervertebral Disc Disorder Procedure: Risk Stratified Care Procedure: Usual Care Not Applicable Detailed Description

2017 Clinical Trials

142. Screen-Based Distraction Tool for Preoperative Preparation

Screen-Based Distraction Tool for Preoperative Preparation Screen-Based Distraction Tool for Preoperative Preparation - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (100). Please remove one or more studies before adding more. Screen-Based Distraction Tool (...) Allocation: Randomized Intervention Model: Parallel Assignment Masking: Single (Outcomes Assessor) Primary Purpose: Treatment Official Title: Screen-Based Distraction Tool for Preoperative Preparation Actual Study Start Date : January 2017 Actual Primary Completion Date : January 2018 Actual Study Completion Date : January 2018 Resource links provided by the National Library of Medicine related topics: Arms and Interventions Go to Arm Intervention/treatment Active Comparator: Tablet Preoperative patients

2017 Clinical Trials

143. Performance of Edmonton Frail Scale on frailty assessment: its association with multi-dimensional geriatric conditions assessed with specific screening tools. Full Text available with Trip Pro

Performance of Edmonton Frail Scale on frailty assessment: its association with multi-dimensional geriatric conditions assessed with specific screening tools. The aim of this study was to evaluate the performance of Edmonton Frail Scale (EFS) on frailty assessment in association with multi-dimensional conditions assessed with specific screening tools and to explore the prevalence of frailty by gender.We enrolled 366 hospitalised patients (women\men: 251\115), mean age 81.5 years. The EFS (...) was given to the patients to evaluate their frailty. Then we collected data concerning cognitive status through Mini-Mental State Examination (MMSE), health status (evaluated with the number of diseases), functional independence (Barthel Index and Activities Daily Living; BI, ADL, IADL), use of drugs (counting of drugs taken every day), Mini Nutritional Assessment (MNA), Geriatric Depression Scale (GDS), Skeletal Muscle Index of sarcopenia (SMI), osteoporosis and functionality (Handgrip strength

2017 BMC Geriatrics

144. Reliability and validity of the Turkish version of the fibromyalgia rapid screening tool (FiRST) Full Text available with Trip Pro

Reliability and validity of the Turkish version of the fibromyalgia rapid screening tool (FiRST) [Purpose] An easy-to-use, psychometrically validated screening tool for fibromyalgia is needed. This study aims to evaluate the reliability and validity of the Turkish version of the Fibromyalgia Rapid Screening Tool by correlating it with 2013 American College of Rheumatology alternative diagnostic criteria and the Hospital Anxiety and Depression Scale. [Subjects and Methods] Subjects were 269 (...) Physical Medicine and Rehabilitation clinic outpatients. Patients completed a questionnaire including the Fibromyalgia Rapid Screening Tool (twice), 2013 American College of Rheumatology alternative diagnostic criteria, and the Hospital Anxiety and Depression Scale. Scale reliability was examined by test-retest. The 2013 American College of Rheumatology alternative diagnostic criteria was used for comparison to determine criterion validity. The sensitivity, specificity, and positive and negative

2017 Journal of physical therapy science

145. A Digital Tool to Promote Alcohol and Drug Use Screening, Brief Intervention, and Referral to Treatment Skill Translation: A Mobile App Development and Randomized Controlled Trial Protocol Full Text available with Trip Pro

about SBIRT), (2) apply skills with patients (ie, build confidence and perceived behavioral control), and (3) report performance data (ie, increase accountability and social norms and/or influence). The app includes depression and anxiety screening tools due to high comorbidity with substance use. A randomized controlled trial (RCT) is in progress among health and social service learners (N=200) recruited from 3 universities and 6 different training programs in nursing, social work, internal (...) A Digital Tool to Promote Alcohol and Drug Use Screening, Brief Intervention, and Referral to Treatment Skill Translation: A Mobile App Development and Randomized Controlled Trial Protocol Translation of knowledge and skills from classroom settings to clinical practice is a major challenge in healthcare training, especially for behavioral interventions. For example, screening, brief intervention, and referral to treatment (SBIRT) is a highly-promoted approach to identifying and treating

2017 JMIR Research Protocols Controlled trial quality: uncertain

146. Development and use of a clinical decision support tool for behavioral health screening in primary care clinics Full Text available with Trip Pro

Development and use of a clinical decision support tool for behavioral health screening in primary care clinics Screening, brief intervention, and referral for treatment (SBIRT) for behavioral health (BH) is a key clinical process. SBIRT tools in electronic health records (EHR) are infrequent and rarely studied. Our goals were 1) to design and implement SBIRT using clinical decision support (CDS) in a commercial EHR; and 2) to conduct a pragmatic evaluation of the impact of the tools (...) on clinical outcomes.A multidisciplinary team designed SBIRT workflows and CDS tools. We analyzed the outcomes using a retrospective descriptive convenience cohort with age-matched comparison group. Data extracted from the EHR were evaluated using descriptive statistics.There were 2 outcomes studied: 1) development and use of new BH screening tools and workflows; and 2) the results of use of those tools by a convenience sample of 866 encounters. The EHR tools developed included a flowsheet for documenting

2017 Applied clinical informatics

147. A Screening Tool to Measure Eye Contact Avoidance in Boys with Fragile X Syndrome Full Text available with Trip Pro

A Screening Tool to Measure Eye Contact Avoidance in Boys with Fragile X Syndrome We examined the reliability, validity and factor structure of the Eye Contact Avoidance Scale (ECAS), a new 15-item screening tool designed to measure eye contact avoidance in individuals with fragile X syndrome (FXS). Internal consistency of the scale was acceptable to excellent and convergent validity with the Social Responsiveness Scale, Second Edition (SRS-2) and the Anxiety, Depression, and Mood Scale (ADAMS (...) ) was good. Boys with a comorbid ASD diagnosis obtained significantly higher scores on the ECAS compared to boys without ASD, when controlling for communication ability. A confirmatory factor analysis indicated that a two-factor model (avoidance and aversion) provided an excellent fit to the data. The ECAS appears to be a promising reliable and valid tool that could be employed as an outcome measure in future pharmacological/behavioral treatment trials for FXS.

2017 Journal of autism and developmental disorders

148. Is the BPRS-5 subscale of the psychotic depression assessment scale a reliable screening tool for psychotic depression?: Results from the CRESCEND Study. (Abstract)

Is the BPRS-5 subscale of the psychotic depression assessment scale a reliable screening tool for psychotic depression?: Results from the CRESCEND Study. The detection of psychotic depression (PD) among patients with depressive disorders is important for both treatment and monitoring. Therefore, in continuation of our previous work, this study aimed to test the ability of the five-item Brief Psychiatric Rating Scale (BPRS-5) of the Psychotic Depression Assessment Scale (PDAS) in separating (...) patients with psychotic depression from those with non-psychotic depression (non-PD) and to compare this discriminative validity to that of other item sets.A receiver operating characteristics curve was used to identify the optimal cut-off score of the BPRS-5 subscale for sensitive and specific distinction between PD and non-PD in a sample of 494 patients with depressive disorders (53 with PD and 441 with non-PD).Using an optimal cut-off score of 1, the sensitivity and the specificity of the BPRS-5

2014 Journal of Affective Disorders

149. The utility of the Edinburgh Depression Scale as a screening tool for depression in Parkinson's disease. Full Text available with Trip Pro

The utility of the Edinburgh Depression Scale as a screening tool for depression in Parkinson's disease. This study aimed to evaluate the Edinburgh Depression Scale (EDS) as a screening tool for use in a Parkinson's disease (PD) population. Many commonly used depression scales include items relating to somatic symptoms that also occur in PD, which could potentially result in inaccurate reporting of depressive symptoms. The EDS is a scale that incorporates no somatic items.One hundred twenty (...) or major depression. The performance characteristics at a range of thresholds were compared.A cut-off score of 10/11 gave maximal discriminant validity, with 74% sensitivity, 92% specificity and 64% positive predictive value for the identification of any depression according to DSM-IV criteria.This study suggests that the EDS is both a valid and potentially useful instrument that can be used as a quick self-completion questionnaire for screening for depression in people who have PD.Copyright © 2014

2014 International Journal of Geriatric Psychiatry

150. Accuracy of case-finding tools for depression in long term care

Accuracy of case-finding tools for depression in long term care Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. CRD bears no responsibility or liability for the content of this registration record, any associated files or external websites. Email salutation (e.g. "Dr Smith" or "Joanne") for correspondence: Organisation web address: Timing and effect measures (...) Timing and effect measures Email salutation (e.g. "Dr Smith" or "Joanne") for correspondence: Organisation web address: Context and rationale Inclusion criteria: Exclusion criteria: Inclusion criteria: Exclusion criteria: Inclusion criteria: Exclusion criteria: Inclusion criteria: Exclusion criteria: Inclusion criteria: Exclusion criteria: Example: Screening will be performed in two phases, namely initial screening based on title and abstract, followed by full-text screening of the eligible articles

2018 PROSPERO

151. Assessing the Accuracy of Machine-Assisted Abstract Screening With DistillerAI: A User Study

screener with a semi-automated screening tool. Methods To address our objective, we employed a diagnostic framework approach that assessed the accuracy of machine-assisted screening compared with a reference (gold) standard. Specifically, we used data from an Agency for Healthcare Research and Quality (AHRQ) comparative effectiveness review on pharmacological and nonpharmacological interventions for the treatment of depression as the reference standard. 22 We chose DistillerAI as a semi-automated (...) 3 Department of Family Medicine, Care and Public Health Research Institute, Maastricht University, Maastricht, The Netherlands AHRQ Publication No. 19(20)-EHC026 -EF November 2019 ii Key Messages Purpose of the report This report summarizes a methods study that evaluated the accuracy of a machine-assisted abstract screening approach that temporarily replaced a human screener with a semi-automated screening tool. Key messages • Results of our study rendered a mean sensitivity of 78 percent

2019 Effective Health Care Program (AHRQ)

152. Helping physicians fatigued by TSH Screening and Subclinical Hypothyroidism

Helping physicians fatigued by TSH Screening and Subclinical Hypothyroidism Tools for Practice is proudly sponsored by the Alberta College of Family Physicians (ACFP). ACFP is a provincial, professional voluntary organization, representing more than 4,800 family physicians, family medicine residents, and medical students in Alberta. Established over sixty years ago, the ACFP strives for excellence in family practice through advocacy, continuing medical education and primary care research (...) . www.acfp.ca December 9, 2019 (en français) Helping physicians fatigued by TSH Screening and Subclinical Hypothyroidism Clinical Question: Is there evidence for screening for thyroid function or treating subclinical hypothyroidism? Bottom Line: There is no randomized controlled trial (RCT) of screening for thyroid function [ordering thyroid stimulating hormone (TSH) in non-pregnant healthy people]. Despite approximately 20 RCTs, there are no patient-oriented benefits (like preventing cardiovascular disease

2019 Tools for Practice

153. Screen-based activities and children and young people’s mental health and psychosocial wellbeing: a systematic map of reviews

: the nature of the screen-based activity examined; the aims of the review; the mental health outcomes assessed; the population focus; and the size of the evidence base and type of synthesis undertaken. Critical appraisal: We assessed the methodological quality of included reviews of quantitative studies by adapting the AMSTAR 2 criteria (Shea et al., 2017). We did not undertake appraisal of the reviews of qualitative studies because of the current lack of a validated/agreed tool for judging the quality (...) ). - Fewer reviews attempted to explore the risk factors (n=6) or consequences (n=11) of screen- based activities by conducting syntheses of longitudinal data. - Even fewer reviews explored CYP’s experience of engagement with screen-based activities by conducting a qualitative evidence synthesis (n=4). Outcomes A wide spectrum of mental health and psychosocial outcomes were investigated across the reviews. These included commonly recognised mental health outcomes such as depression and anxiety

2018 EPPI Centre

154. Human Immunodeficiency Virus (HIV) Infection: Screening

Human Immunodeficiency Virus (HIV) Infection: Screening Recommendation | United States Preventive Services Taskforce Toggle navigation Main navigation Main navigation Recommendation Pregnant persons The USPSTF recommends that clinicians screen for HIV infection in all pregnant persons, including those who present in labor or at delivery whose HIV status is unknown. A Adolescents and adults aged 15 to 65 years The USPSTF recommends that clinicians screen for HIV infection in adolescents (...) and adults aged 15 to 65 years. Younger adolescents and older adults who are at increased risk of infection should also be screened. A View the Clinical Summary in Population Adolescents and adults aged 15 to 65 years Pregnant Persons Recommendation Screen for HIV infection. Grade: A Screen for HIV infection. Grade: A Risk Assessment Although all adolescents and adults aged 15 to 65 years should be screened, there are a number of risk factors that increase risk. Among adolescents younger than 15 years

2019 U.S. Preventive Services Task Force

155. Abdominal Aortic Aneurysm: Screening

%-100%) and specificity (98%-100%) for detecting AAA, , and does not expose patients to radiation. Computed tomography is an accurate tool for identifying AAA; however, it is not recommended as a screening method because of the potential for harms from radiation exposure. Physical examination has been used in practice but has low sensitivity (39%-68%) and specificity (75%) and is not recommended for screening. Screening Intervals Evidence is adequate to support 1-time screening for men who have ever (...) - to 15-year follow-up. Five studies (n = 2734) reported mixed results on quality-of-life outcomes. Overall, there were no substantial differences on quality-of-life measures or anxiety or depression scores at up to 12 months of follow-up between patients who screened positive for an AAA and patients who screened negative or were unscreened. Two trials of early open repair vs surveillance (ADAM and UKSAT trials) reported a 50% higher rate of procedures in the early intervention group

2019 U.S. Preventive Services Task Force

156. Screening and Management of Bleeding Disorders in Adolescents With Heavy Menstrual Bleeding

tests. The obstetrician–gynecologist should be aware of risk factors and comorbidities associated with bleeding disorders. Medical History When obtaining a medical history, it is important to identify risk factors for bleeding disorders as well as medical conditions that would alter management. See for a recommended screening tool for adolescent patients who report heavy menstrual bleeding. Adolescents who meet the criteria detailed in Box 1 should undergo laboratory screening for a bleeding (...) Screening and Management of Bleeding Disorders in Adolescents With Heavy Menstrual Bleeding Screening and Management of Bleeding Disorders in Adolescents With Heavy Menstrual Bleeding - ACOG Menu ▼ Screening and Management of Bleeding Disorders in Adolescents With Heavy Menstrual Bleeding Page Navigation ▼ Number 785 Committee on Adolescent Health Care This Committee Opinion was developed by the American College of Obstetricians and Gynecologists’ Committee on Adolescent Health Care

2019 American College of Obstetricians and Gynecologists

157. Canadian Cardiovascular Society/Canadian Heart Rhythm Society Joint Position Statement on the Cardiovascular Screening of Competitive Athletes Full Text available with Trip Pro

” refer to a symptom, sign, history, or abnormality for which further investigation is strongly recommended by existing contemporary guidelines. In this statement, we refer to and contextualize the utility of these tools rather than list each possible “red flag.” Potential or emerging bedside screening tools (ie, ultrasound and molecular diagnostics) were not considered in the present scope. CV screening is usually undertaken specifically to assess the risk of SCD during or related to sport (...) Canadian Cardiovascular Society/Canadian Heart Rhythm Society Joint Position Statement on the Cardiovascular Screening of Competitive Athletes Canadian Cardiovascular Society/Canadian Heart Rhythm Society Joint Position Statement on the Cardiovascular Screening of Competitive Athletes - Canadian Journal of Cardiology Email/Username: Password: Remember me Search Terms Search within Search Share this page Access provided by Volume 35, Issue 1, Pages 1–11 Canadian Cardiovascular Society/Canadian

2018 Canadian Cardiovascular Society

158. New insights into the prevalence of depressive symptoms and depression in rheumatoid arthritis - Implications from the prospective multicenter VADERA II study. Full Text available with Trip Pro

symptoms was 55.4% (mild or worse) and 22.8% (moderate or worse). Characteristics independently associated with depressive symptomatology were: age <60 years (OR = 1.78), RAID score >2 (OR = 10.54) and presence of chronic pain (OR = 3.25). Of patients classified as having depressive symptoms, only 11.7% were receiving anti-depressive therapy.Mild and moderate depressive symptoms were common in RA patients according to validated tools. In routine clinical practice, screening for depression (...) New insights into the prevalence of depressive symptoms and depression in rheumatoid arthritis - Implications from the prospective multicenter VADERA II study. To investigate the prevalence of depressive symptoms in rheumatoid arthritis (RA) patients using two previously validated questionnaires in a large patient sample, and to evaluate depressive symptoms in the context of clinical characteristics (e.g. remission of disease) and patient-reported impact of disease.In this cross-sectional study

2019 PLoS ONE

159. Repetitive transcranial magnetic stimulation for treatment-resistant major depression

(i.e. HTA reports and systematic reviews/SRs) were screened as a first step and evaluated on the basis of their scope, inclusion and exclusion criteria, and quality. Primary studies were considered for inclusion in the second step. The AMSTAR tool was used for quality assessment of SRs. The Health Quality Ontario (HQO) report [13] was selected for update. As a second step, to identify further, more recent, primary studies fulfilling the inclusion criteria of the present assessment, a literature (...) Repetitive transcranial magnetic stimulation for treatment-resistant major depression Dec2015 © EUnetHTA, 2015. Reproduction is authorised provided EUnetHTA is explicitly acknowledged 1 EUnetHTA Joint Action 3 WP4 Version 4, 30 March 2017 Rapid assessment of other technologies using the HTA Core Model ® for Rapid Relative Effectiveness Assessment REPETITIVE TRANSCRANIAL MAGNETIC STIMULATION FOR TREATMENT-RESISTANT MAJOR DEPRESSION Project ID: OTCA05 HF-rTMS for TRD Error! Use the Home tab

2017 EUnetHTA

160. Single-item measures for depression and anxiety: Validation of the Screening Tool for Psychological Distress in an inpatient cardiology setting. (Abstract)

Single-item measures for depression and anxiety: Validation of the Screening Tool for Psychological Distress in an inpatient cardiology setting. Depression and anxiety are common among patients with cardiovascular disease (CVD) and confer significant cardiac risk, contributing to CVD morbidity and mortality. Unfortunately, due to the lack of screening tools that address the specific needs of hospitalized patients, few cardiac inpatient programs offer routine screening for these forms (...) of psychological distress, despite recommendations to do so.The purpose of this study was to validate single-item measures for depression and anxiety among cardiac inpatients.Consecutive inpatients were recruited from the cardiology and cardiac surgery step-down units at a university-affiliated, quaternary-care hospital. Subjects completed a questionnaire that included: (a) demographics, (b) single-item-measures for depression and anxiety (from the Screening Tool for Psychological Distress (STOP-D)), and (c

2014 European Journal of Cardiovascular Nursing

To help you find the content you need quickly, you can filter your results via the categories on the right-hand side >>>>